Lessina Kit
Product Images NDC 0555-9014

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lessina (NDC 0555-9014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

FDA Label Image

Image 2

FDA Label Image

Image 3

Image 3
Mean Levonorgestrel and Ethin Estradiol Concentrations were tested in serum after a single dose and on day 21 of cycles 1 and 3. The graph shows the results of the tests conducted for levonorgestrel where the concentration was 5000 at a single dose and decreased gradually over time, and the concentrations for ethin estradiol were tested at a single dose and on day 21 of cycles 1 and 3. The graph depicts the ethin estradiol concentrations decreasing gradually over time.*
FDA Label Image

Image 4

Image 4
This is a table of different studies related to women's contraceptive use. The studies are from different years and some analyze ever use of contraceptives while others analyze current use of contraceptives. There is also an effect estimate for each study. No further information is available.*
FDA Label Image

Image 5

Image 5
This is a label or instruction for storing medication named "Lejjma" which contains two active ingredients, levonorgestrel, and ethinyl estradiol. The medication should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and should be kept at the US Pharmacopeia controlled room temperature.*
FDA Label Image

Image 6

FDA Label Image

Image 7

Image 7
This is a description of a medication in blister card packaging. The medication is a combination of levonorgestrel and ethinyl estradiol tablets, intended for the prevention of pregnancy. The tablets have a strength of 0.1mg/0.02mg. The product does not provide protection against HIV or other sexually transmitted diseases. The manufacturer is Teva Pharmaceuticals, based in North Wales, PA.*
FDA Label Image

Image 8

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.